📢 Latest Update

FDA shifts 60-year default: One pivotal clinical trial is now the default for drug approval – replacing the two-trial requirement

Read the full story →

Contact us
Contact us

Our Research & Development Pipeline

Focused on data-driven therapeutic development across key disease domains using AI, genomics, and advanced computational modeling.

Our mission

Current Focus Areas

To improve human health by accelerating the world’s transition to precision medicine

1.Oncology Precision Therapeutics

  • Personalized Therapy models for: Multiple Myeloma. Solid Tumors such as Non Small Cell Lung Cancer
  • Advanced combination therapy design
  • Resistance mechanism prediction

2.Neurodegenerative Disease Modeling

  • ALS computational intervention strategies
  • Alzheimer’s progression prediction
  • Personalized neurological intervention design

3.Rare Genetic Disorder Research

  • Comprehensive genetic variant analysis
  • Personalized intervention strategies
  • Population-level genetic risk modeling

4.Metabolic Health Platform

  • Diabetes progression prediction
  • Personalized metabolic intervention design
  • Lifestyle optimization modeling

Connect with

GNQ

Explore collaboration opportunities and learn how our platform can support your research and development initiatives.

Contact us
Contact us